Di Nuzzo Private Wealth, Inc. Halozyme Therapeutics, Inc. Transaction History
Di Nuzzo Private Wealth, Inc.
- $618 Million
- Q4 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 13 shares of HALO stock, worth $764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 13
-0.0%
Holding current value
$764
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HALO
# of Institutions
555Shares Held
124MCall Options Held
668KPut Options Held
259K-
Black Rock Inc. New York, NY17.6MShares$1.04 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$781 Million0.01% of portfolio
-
State Street Corp Boston, MA7.18MShares$422 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.17MShares$245 Million4.34% of portfolio
-
Bank Of America Corp Charlotte, NC3.45MShares$203 Million0.01% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.19B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...